The role of the pharmacist in the COVID-19 pandemic: An integrative review




Coronavirus; COVID-19; Pharmacy service; Pharmaceutical care; Hospital pharmacy.


Objective: To analyze the scientific literature regarding the role of the pharmacist in the COVID-19 pandemic, through an integrative literature review. Data source: The search for scientific articles was carried out in the following databases: Virtual Health Library (VHL), Latin American and Caribbean Literature in Health Sciences (LILACS), Scientific Eletronic Library Online (SciELO) and PubMed in period from 2019 to 2020. The inclusion criteria established were publications in English with the descriptor “Coronavirus, COVID-19, Pharmacy, Community Pharmacy, Pharmacy Services, Pharmaceutical Care, Hospital Pharmacy” in the title, abstract or keywords in available articles online and in full. Letters to the editor and duplicate articles were excluded. Summary of the findings: 10,906 articles were identified, of which 28 met the selection criteria. The results were demonstrated with emphasis on the additional functions performed by pharmacists both in the community pharmacy and in the hospital pharmacy, determined by the pandemic situation. At the hospital level, support for clinical decision-making on pharmacotherapy, logistical management of medications, greater security in dispensing medication and pharmacovigilance were verified. In the community pharmacy environment, the emphasis was on pharmaceutical care directly to the user through guidance on hygiene measures seeking to minimize or prevent the spread of the virus and contamination of people. Maintaining the dispensing of medications for acute and chronic users, by guaranteeing the supply and availability of quality medications, was the main activity, as well as rapid tests for diagnoses of COVID-19.


Al-Quteimat, O., Amer, A. M. (2021). SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm, 17(2), 480-482.

Alderman, C. Pharmacy Services and the Novel Coronavirus. (2020). Sr Care Pharm, 35(4), 146-147.

Amariles, P., Ledezma-Morales, M., Salazar-Ospina, A., Hincapié-Garcia, J. A., (2021). How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm, 17(1), 1988-1989.

Arain,S., Thalapparambayh, R., Al Ghandi, F. H. (2020). COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department. Res Social Adm Pharm, 17(1), 2009-2011.

Bahlol, M., Dewey, R. S. (2020). Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm, 17(1), 1888-1898.

Basheti,I. A., Nassar, R., Barakat, M., Alqudah, R., Abufarha, T., Mukattash, L., Saini, B. (2020). Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm, 17(3), 514-522.

Bukhari, N., Rasheed, U., Nayyer, B., Babar, Z. U. D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract 13, 8 (2020).

Cadogan, C. A., Hughes, C. M. (2020). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm, 17(3), 514-522. DOI:10.1186/s40545-020-00210-w

Carico, R., Sheppatd, J., Thomas, C. B. (2021). Community pharmacists and communication in the time of COVID-19: Applying the health belief model. Res Social Adm Pharm, 17(1), 1984-1987.

Dawoud, D. (2021). Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Social Adm Pharm, 17(1): 1950–1953.

Erku, D. A., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., Tesfaye, H. (2020). When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the “infodemic” surrounding COVID-19. Res Social Adm Pharm, 17(1), 1954-1963.

Fitzgerald, T.J. Kang, Y., Bridges, C. B., Talbert, T., Vagi, S. J., Lamont, B., Gratcer, S. B. (2016). Integrating pharmacies into public health program planning for pandemic influenza vaccine response. Vaccine, 34(46), 5643–5648.

Hedima, E. W., Adeyemi, M. S,m Ikunaiye, N. Y.(2020). Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social Adm Pharm, 17(1), 1964-1966.

Hua, X. L., Gu, M., Zeng, F., Hu, H., Zhou, T., Zhang, Y., Shi, C. (2020) Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc, 60(3), 431- 438.

Hussain, R., Dawoud, D. M., Babar, Z. U. D. (2020). Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Res Social Adm Pharm, 17(1), 1920-1924.

International Pharmaceutical Federation (FIP Health Advisory). Coronavirus 2019-nCoV Outbreak. Information and interim guidelines for pharmacists and the pharmacy workforce. Netherlands, 2020. Disponível em:: Acesso em: 30 out 2020.

Jiang,S. Death Toll Rises to 25. CNN; 2020. Disponível em: Acesso em: 29 out 2020.

Koster, E., Philbert, D., Bouvy, M. L.(2021). Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm,17(1), 2002-2004.

Li, H., Sigian, Z., Fang, L., Wei, L., Rongsheng, Z. (2021) Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm, 17(1), 1813-1818.

Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm, 42(2):299-304.

Lu, C., Liu, X., Jia, Z. (2020). 2019-nCoV transmission through the ocular surface must not be ignored.

Lancet, 22(395) (10224):e39.

Meng, L., Qiu, F., Sun, S. (2020). Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China. Int J Clin Pharm, 2 : 1–4.

Santos, L. E. S. dos; Santos, L. S. dos. (20210. The impact of the coronavirus on patients with heart diseases. Research, Society and Development, 10(5), e0110514539.

Sethuraman, N., (2020). Interpreting diagnostic tests for SARS-CoV-2. JAMA. 6, 2020.

Song, Z., Hu, Y., Zheng, S., Yang, L., Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Res Social Adm Pharm, 17(1):2027-2031.

Souza, M. T., Silva, M. D., Carvalho, R. (2010). Integrative review: what is it? How to do it?. Einstein, 6(1), 102-6.

Stergachis, A. (2020). Preparing pharmacy for the surge of patients with COVID-19: Lessons from China. J Am Pharm Assoc, 60(3): 423–424.

Sum, Z. Z., OW, C. J. W. (2021). Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm, 17(1):1845-1852.

The Straits Times. First Death outside China in Philippines; 2020. Published https :// Acesso em: 28 out 2020.

Ung, C. O. L. (2020). Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm, 16(4):583-586.

Uzunian, A. (2020). Coronavírus SARS-CoV-2 e COVID-19. J Bras Patol Med Lab, 56: 1-4.

Vellano, P. O., Paiva, M. J. M. (2020). O uso de antimicrobiano na COVID-19 e as infecções: o que sabemos. Research, Society and Development, 9(6), e841997245.

Visacri, M. B., Figueiredo, I. V., Lima, T. M.(2021). Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social Adm Pharm, 17(1), 1799-1806.

Wiersinga, W. J., Rodhes, A., Cheng, A. C., Peacock, S., Prescott, H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 324(8), 782-793.

World Health Organization. Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations. odes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-r ecommendations. Acesso em: 28 out 2020.

Ying,W., Qian, Y., Kun, Z. (2021). Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm, 17(1), 1978-1983.

World Heath Organization. Coronavirus Disease (COVID-19) - events as they happen. Disponível em: Acesso em: 28 out 2020.

World Heath Organization. Coronavirus disease 2019 (COVID-19) - situation report – 72. Disponível em: ovid-19.pdf?sfvrsn¼3dd8971b_2; 2020b. Acesso em: 28 out 2020.

Zaidi, S. T. R., Hasan, S., Saidi, S. T. R., Hasan, S. S.(2020). Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm, 17(1), 1832-1837.

Zheng, S., Yang, L., Zhou, P. X., Li, H., Liu, F. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm, 17(1), 1819-1824.

Zuckerman, A. D., (2020). From natural disaster to pandemic: A health-system pharmacy rises to the challenge. Am J Health Syst Pharm, 77(23), 1986–1993.



How to Cite

PASSOS, M. M. B. dos .; CASTOLDI, V. de M.; SOLER, O. The role of the pharmacist in the COVID-19 pandemic: An integrative review. Research, Society and Development, [S. l.], v. 10, n. 6, p. e27110615809, 2021. DOI: 10.33448/rsd-v10i6.15809. Disponível em: Acesso em: 20 may. 2024.



Health Sciences